{"id":"https://openalex.org/W4361817992","doi":"https://doi.org/10.1158/1078-0432.22465814.v1","title":"Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors","display_name":"Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361817992","doi":"https://doi.org/10.1158/1078-0432.22465814.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22465814.v1","doi":"https://doi.org/10.1158/1078-0432.22465814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22465814.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22465814.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007900554","display_name":"Wael Jdey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wael Jdey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112795955","display_name":"Sylvain Thierry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvain Thierry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103740954","display_name":"Christophe Russo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christophe Russo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053245222","display_name":"Flavien Devun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Flavien Devun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023082338","display_name":"Muthana Al Abo","orcid":"https://orcid.org/0000-0001-6028-3688","observed_orcids":["https://orcid.org/0000-0001-6028-3688"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muthana Al Abo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006380747","display_name":"P. Noguiez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Noguiez-Hellin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076452008","display_name":"Jian\u2010Sheng Sun","orcid":"https://orcid.org/0000-0003-0614-1931","observed_orcids":["https://orcid.org/0000-0003-0614-1931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian-Sheng Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062067186","display_name":"Emmanuel Barillot","orcid":"https://orcid.org/0000-0003-2724-2002","observed_orcids":["https://orcid.org/0000-0003-2724-2002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmanuel Barillot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077253721","display_name":"Andrei Y. Zinovyev","orcid":"https://orcid.org/0000-0002-9517-7284","observed_orcids":["https://orcid.org/0000-0002-9517-7284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrei Zinovyev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029262309","display_name":"Inna Kuperstein","orcid":"https://orcid.org/0000-0001-8086-8915","observed_orcids":["https://orcid.org/0000-0001-8086-8915"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inna Kuperstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042114293","display_name":"Yves G. Pommier","orcid":"https://orcid.org/0000-0002-3108-0758","observed_orcids":["https://orcid.org/0000-0002-3108-0758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yves Pommier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062946213","display_name":"Marie Dutreix","orcid":"https://orcid.org/0000-0002-3242-4815","observed_orcids":["https://orcid.org/0000-0002-3242-4815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie Dutreix","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9380000233650208},{"id":"https://openalex.org/keywords/asidna","display_name":"AsiDNA","score":0.9580000042915344},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9100000262260437},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-cell-survival","display_name":"tumor cell survival","score":0.7519999742507935},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.527999997138977},{"id":"https://openalex.org/keywords/trypan-blue-staining","display_name":"trypan blue staining","score":0.8009999990463257},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.8942350149154663},{"id":"https://openalex.org/C2780070996","wikidata":"https://www.wikidata.org/wiki/Q61482373","display_name":"Trypan blue","level":3,"score":0.7551801204681396},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.6441988945007324},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5363171696662903},{"id":"https://openalex.org/C117220453","wikidata":"https://www.wikidata.org/wiki/Q5172842","display_name":"Correlation","level":2,"score":0.5276963710784912},{"id":"https://openalex.org/C2986115478","wikidata":"https://www.wikidata.org/wiki/Q186290","display_name":"Positive correlation","level":2,"score":0.4255949854850769},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3768497407436371},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.373357355594635},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.35945549607276917},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34286415576934814},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.340579628944397},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32831698656082153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2943468689918518},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28743839263916016},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.1122819185256958},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.08937439322471619},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.08283841609954834},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.08080899715423584},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22465814.v1","doi":"https://doi.org/10.1158/1078-0432.22465814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22465814.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22465814.v1","doi":"https://doi.org/10.1158/1078-0432.22465814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22465814.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005702181","https://openalex.org/W4229451438","https://openalex.org/W3172380618","https://openalex.org/W2746104128","https://openalex.org/W2507994885","https://openalex.org/W4362541711","https://openalex.org/W2514291160","https://openalex.org/W4361817964","https://openalex.org/W2966931594","https://openalex.org/W4361818171"],"abstract_inverted_index":{"Supplementary":[0],"figure":[1],"S2.":[2],"Correlation":[3,37],"between":[4,39],"sensitivity":[5],"of":[6,32],"tumor":[7],"cells":[8],"to":[9,41],"AsiDNA":[10,42],"and":[11,20,43,50],"olaparib.":[12],"Survival":[13],"was":[14,45],"moniored":[15],"by":[16],"trypan":[17],"blue":[18],"staining":[19],"manual":[21],"counting":[22],"(6":[23],"days":[24],"after":[25],"treatment).":[26],"Survivals":[27],"are":[28],"expressed":[29],"as":[30],"%":[31],"living":[33],"non":[34,53],"treated":[35],"cells.":[36],"analysis":[38],"survival":[40],"olaparib":[44],"performed":[46],"using":[47],"GraphPadPrism5":[48],"software":[49],"indicates":[51],"a":[52],"significant":[54],"correlation.":[55]},"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2025-10-10T00:00:00"}